Netherlands: argenx to acquire Forte Biosciences for US$2.2bn
Dutch/Belgian Euronext- and Nasdaq-listed argenx, a global immunology innovation company, is to acquire Nasdaq-listed Forte Biosciences, a clinical-stage…
Browsing Tag